Yifan Pharmaceutical (002019.SZ): The registration application for the disperse granules of Methotrexate Hydrochloride has been accepted.

Hexun Finance APP News, Yifan Pharmaceutical (002019.SZ) announced that its wholly-owned subsidiary Sichuan Defeng Pharmaceutical Co., Ltd. recently received the "Acceptance Notice" for the application for registration and listing of domestically produced hydrochloride mercaptopurine dispersible tablets issued by the National Medical Products Administration (referred to as "NMPA").